The real-world weight loss effectiveness of GLP-1RAs have not been well described. We conducted a cohort study using EHR data from an integrated healthcare system based in PA. Non-pregnant adults first dispensed a GLP-1RA between 20 and 2018 were eligible. We excluded those without:
1) at least 72 weeks of continuous enrollment after the first dispense date,
2) at least 1 year of baseline enrollment data, and
3) at least one valid weight measurement within the 8 wks before the dispense date and at least one weight measure during follow-up.
Disclosure
J.Luo: None. I.Shu: None. M.T.Korytkowski: None. D.A.Rometo: Advisory Panel; Nestlé Health Science. J.Arnold: None. G.E.White: None.
Funding
NIDDK (K23ADK120956)
© 2022 by the American Diabetes Association
2022
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.